Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 44, 2018 - Issue 6
Submit an article Journal homepage
378
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Preparation and evaluation of carfentanil nasal spray employing cyclodextrin inclusion technology

Peng YangDepartment of Pharmacy, XuZhou Medical University, Xuzhou, China; ;State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; View further author information
,
Ying LiState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; View further author information
,
Wanqing LiSchool of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing, ChinaView further author information
,
Hui ZhangState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; View further author information
,
Jing GaoState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; View further author information
,
Jianxu SunState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; View further author information
,
Xiaoxing YinDepartment of Pharmacy, XuZhou Medical University, Xuzhou, China; Correspondence[email protected]
View further author information
&
Aiping ZhengDepartment of Pharmacy, XuZhou Medical University, Xuzhou, China; ;State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; Correspondence[email protected] [email protected]
View further author information
 show all
Pages 953-960 | Received 31 Jan 2017, Accepted 27 Dec 2017, Published online: 06 Feb 2018

References

  • George AV, Lu JJ, Pisano MV, et al. Carfentanil—an ultra potent opioid. Am J Emerg Med. 2010;28:530–532.
  • Lust EB, Barthold C, Malesker MA, et al. Human health hazards of veterinary medications: information for emergency departments. J Emerg Med. 2011;40:198–207.
  • Mick I, Myers J, Stokes PRA, et al. Amphetamine induced endogenous opioid release in the human brain detected with [11C]carfentanil PET: replication in an independent cohort. Int J Neuropsychopharmacol. 2014;17:2069–2074.
  • Jug M, Bećirević-Laćan M. Development of a cyclodextrin-based nasal delivery system for lorazepam. Drug Dev Ind Pharm. 2008;34:817–826.
  • Yin CW, Zhong Z. Intranasal delivery—modification of drug metabolism and brain disposition. Pharm Res. 2010;27:1208–1223.
  • Colombo G, Lorenzini L, Zironi E, et al. Brain distribution of ribavirin after intranasal administration. Antiviral Res. 2011;92:408–414.
  • DrugBank. Available from: http://www.drugbank.ca/drugs/DB01535
  • Yong YH, Dong CS, Nam YS, et al. Characterization, stability, and pharmacokinetics of sibutramine/β-cyclodextrin inclusion complex. J Ind Eng Chem. 2012;18:1412–1417.
  • Fraceto LF, Grillo R, Sobarzo-Sánchez E. Cyclodextrin inclusion complexes loaded in particles as drug carrier systems. Curr Top Med Chem. 2014;14:518–525.
  • Liu J, Qiu L, Gao J, et al. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin. Int J Pharm. 2006;312:137–143.
  • Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res. 2004;21:201–230.
  • Mura P. Analytical techniques for characterization of cyclodextrin complexes in aqueous solution: a review. J Pharm Biomed Anal. 2014;101:238–250.
  • Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 1996;85:1017–1025.
  • Mura P, Faucci MT, Parrini PL. Effects of grinding with microcrystalline cellulose and cyclodextrins on the ketoprofen physicochemical properties. Drug Dev Ind Pharm. 2001;27:119–128.
  • Salústio PJ, Feio G, Figueirinhas JL, et al. The influence of the preparation methods on the inclusion of model drugs in a β-cyclodextrin cavity. Eur J Pharm Biopharm. 2009;71:377–386.
  • Fini A, Fernàndez-Hervàs MJ, Holgado MA, et al. Fractal analysis of beta-cyclodextrin-indomethacin particles compacted by ultrasound. J Pharm Sci. 1997;86:1303–1309.
  • Nozawa Y, Morioka Y, Sadzuka Y, et al. Mechano-chemical formation of indomethacin β cyclodextrin inclusion compounds in powder phase roll mixtures. Pharm Acta Helv. 1997;72:113–117.
  • Pose-Vilarnovo B, Perdomo-López I, Echezarreta-López M, et al. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state. Eur J Pharm Sci. 2001;13:325–331.
  • Moyano JR, Arias-Blanco MJ, Ginés JM, et al. Solid-state characterization and dissolution characteristics of gliclazide-β-cyclodextrin inclusion complexes. Int J Pharm. 1997;148:211–217.
  • Montassier P, Duchêne D, Poelman MC. Inclusion complexes of tretinoin with cyclodextrins. Int J Pharm. 1997;153:199–209.
  • Dittert LW, Higuchi T, Reese DR. Phase solubility technique in studying the formation of complex salts of triamterene. J Pharm Sci. 1964;53:1325–1328.
  • Kim JE, Cho HJ, Kim DD. Budesonide/cyclodextrin complex-loaded lyophilized microparticles for intranasal application. Drug Dev Ind Pharm. 2014;40:743–748.
  • Santra S, Yang H, Stanley JT, et al. Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. Chem Commun (Camb). 2005;25:3144–3146.
  • Wen Z, Yan Z, He R, et al. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration. Drug Deliv. 2011;18:555–561.
  • Gao X, Tao W, Lu W, et al. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials. 2006;27:3482–3490.
  • Merkus FW, Verhoef JC, Marttin E, et al. Cyclodextrins in nasal drug delivery. Adv Drug Deliv Rev. 1999;36:41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.